FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a cytidine derivative applicable in oncology of formula (I):
,
where R1 is C1-C10 alkyl, -(CH2)n-Ph, where n equals 1, Ph is phenyl, optionally substituted with a nitro group or a halogen atom; R2 is 
, where X1 is -(CH2)n-Ph, in which n equals 1; R3 is H or 
where X3 is a substituted heterocyclic ring which is substituted with three halogen atoms; wherein said heterocyclic ring is pyridine; and X2 is -O-(CH2)n-, where n equals 1.
EFFECT: what is presented is a new cytidine derivative with reduced toxicity and pharmaceutical compositions based thereon, effective for treating a malignant solid tumor.
5 cl, 17 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL DIMERS OF CYTIDINE DERIVATIVES AND USE THEREOF | 2015 |
|
RU2687252C2 |
| DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
| SUBSTITUTED INDOLE COMPOUNDS AS REDUCING REGULATORS OF ESTROGEN RECEPTORS | 2017 |
|
RU2722441C2 |
| PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF | 2014 |
|
RU2674977C2 |
| HETEROCYCLIC NITROGEN PYRROLE DERIVATIVES, PRODUCING THEM AND PHARMACEUTICAL APPLICATION | 2008 |
|
RU2473543C2 |
| PIPERIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | 2015 |
|
RU2669701C2 |
| DIHYDROINDOLONE DERIVATIVES | 2009 |
|
RU2468022C2 |
| COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF | 2020 |
|
RU2819762C1 |
| LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
| 2-(2-OXOINDOLIN-3-YLIDENE)METHYL-5-(2-HYDROXY-3-MORPHOLIN-4-YLPROPYL)-6,7-DIHYDRO-1-H-PYRROLE[3,2-C]PYRIDIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS PROTEIN KINASE INHIBITORS | 2008 |
|
RU2472792C2 |
